Skip to content
Search

Latest Stories

ICMR defends India's COVID-19 testing strategy

THE Indian Council of Medical Research(ICMR) has clarified that the testing ratio in India is not low.

It added that there has been no COVID-19 infections in 325 of the 736 districts.


India has 13,387 coronavirus positive cases in the country with 437 deaths.

Recently, congress leader Rahul Gandhi said that India was not conducting enough coronavirus tests.

India also received the much-awaited 500,000 rapid COVID-19 testing kits from China on Thursday (16), the government said.

"In countries like Japan, one out of 11.7 tests turns out to be positive, which is among the highest in the world. Italy tests 6.7 persons for one positive test while the US tests 5.3 persons and the United Kingdom 3.4," said Dr Raman R Gangakhedkar, head of epidemiology and communicable diseases at the ICMR.

"In India, we are conducting 24 tests out of which one comes out to be positive. Also, we have huge population and not all people belong to vulnerable groups. Hence, can't say our testing ratio is low".

Rahul Gandhi said that aggressive testing is the main weapon to defeat the coronavirus and it should be used strategically.

Gangakhedkar said the testing kits from China will be used for surveillance and to monitor whether coronavirus hotspots in the country are increasing or decreasing.

Coronavirus cases crossed 1,000 in Madhya Pradesh(1,090) and Rajasthan(1,104)  taking to five the states which have surpassed this mark.

Maharashtra topped the tally at 3,081 with Mumbai (2,043) being the worst hit followed by Delhi(1,578) and Tamil Nadu(1,267). The cases in Mumbai have doubled in six days.

The Centre has declared 170 hotspots--123 hotspot districts with large outbreaks and 47 hotspot districts with cluster-- in 25 states and Union territories.

Besides, it has identified 207 non-hotspot districts with clusters in 27 states which can be potential hot spots if there is no containment strategies.

More For You

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Sinha’s message was one of resilience and realism

Getty

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Paul Sinha, known to viewers of ITV’s The Chase as “The Sinnerman,” has spoken candidly about his experience living with Parkinson’s disease. During an appearance on Loose Women on Thursday, 17 April, the comedian and quizzer reflected on his journey from diagnosis to managing the condition day to day.

Sinha, who was diagnosed with the progressive neurological disorder in 2019, revealed that his earliest symptoms were not what many would typically associate with Parkinson’s.

Keep ReadingShow less
Toblerone dark chocolate discontinued in the UK, confirms Mondelez

This reflects both the popularity of the product and the frustration of fans

iStock

Toblerone dark chocolate discontinued in the UK, confirms Mondelez

Toblerone fans in the UK will no longer be able to purchase the dark chocolate version of the iconic Swiss chocolate bar, as manufacturer Mondelez has confirmed it has discontinued the product.

The company stated that it has made the “difficult decision” to stop production of the 360g Toblerone Dark bar. While no specific reason was given, Mondelez acknowledged the disappointment it may cause among consumers. A spokesperson said: “While we understand that this may be disappointing for some consumers, we continue to invest in Toblerone.”

Keep ReadingShow less
Crispello Comeback: Cadbury’s Light Treat Hits B&M Shelves

The return to UK shelves has brought a wave of nostalgia for many

Getty

Cadbury Crispello chocolate bars return to UK shelves at B&M for 49p

Cadbury's Crispello chocolate bars have made a surprise return to UK stores, now available at B&M for just 49p. The product, a mix of light wafer and smooth chocolate, had previously been discontinued in the UK and was only available overseas in recent years.

Each individual pack of Crispello contains four chocolate-covered wafer fingers, filled with a creamy chocolate centre. The sweet treat has gained attention on social media, with shoppers expressing their excitement about its reappearance in British stores.

Keep ReadingShow less
 Sharon Osbourne

Celebrities including Sharon Osbourne and Oprah Winfrey might be exhibiting signs of this side effect

Instagram/ Sharonosbourne

‘Ozempic feet’ joins growing list of unusual side effects linked to popular weight-loss drug

Ozempic, the blockbuster weight-loss medication that has surged in popularity across the United States and among celebrities, is now being linked to a new and unexpected side effect like sagging skin on the feet, informally dubbed “Ozempic feet”.

Medical experts say the condition is caused by rapid fat loss, which not only alters the appearance of the face and buttocks, but can also lead to aesthetic changes in the feet. As the drug continues to make headlines for its weight-loss benefits, concerns about such side effects are also gaining attention.

Keep ReadingShow less